Esperer Bio-Research Private Limited, a active private limited company, was established on 16 August 2018 in Mumbai, Maharashtra, India. Engaging in oncology clinics & cancer treatment within the professional, scientific and technical sector, it holds CIN: U24304MH2018PTC312841. Registered under ROC Roc Mumbai. it is unlisted. It has an authorized capital of ₹6.50 Cr and a paid-up capital of ₹4.40 Cr.
Employing 12 professional, Its leadership includes Venkataktyayani Sushmitha Gorantla (Director), Sudipta Chattopadhyay (Director), Shubhankar Karmakar (Director). Past directors included Venkataktyayani Sushmitha Gorantla, Shivshankar Gangaram Bangar, Shubhankar Karmakar. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at Office No. 4Ba, 4Th Floor, Gundecha Onclave, Kherani Road, Sakinaka, Kurla W, Mumbai, Maharashtra, 400072.
U24304MH2018PTC312841
312841
16 August 2018
₹6.50 Cr
₹4.40 Cr
Roc Mumbai
Unlisted
Active
Explore comprehensive insights into Esperer Bio-Research Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Venkataktyayani Sushmitha Gorantla | Director | 23 Feb 2021 | Current |
| Sudipta Chattopadhyay | Director | 12 Mar 2020 | Current |
| Shubhankar Karmakar | Director | 01 Jan 2020 | Current |
| Sohilkumar Dahyabhai Tandel | Director | 16 Aug 2018 | Current |
| Raktim Chattopadhyay | Director | 16 Aug 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Additional Director | 06 Jul 2021 | Past |
| Pramod Abcsdd | Director | 12 Mar 2021 | Past |
| Pramod Abcsdd | Additional Director | 31 Dec 2020 | Past |
| Pramod Abcsdd | Director | 03 Jan 2024 | Past |
| Pramod Abcsdd | Director | 31 Mar 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Esperer Bio-Research Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 57.26% decrease. The company also saw a substantial fall in profitability, with a 502.02% decrease in profit. The company's net worth observed a substantial decline by a decrease of 314.58%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2023, Esperer Bio-Research had a promoter holding of 96.67% and a public holding of 3.33%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Esperer Bio-Research has a workforce of 12 employees as of Mar 31, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Gain comprehensive insights into the Deals and Valuation data of Esperer Bio-Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Esperer Bio-Research's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Esperer Bio-Research Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
Progress on Esperer Bio-Research Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Mumbai. was documented.
Venkataktyayani Sushmitha Gorantla was appointed as a Director was appointed as a Director on 23 Feb 2021 & has been associated with this company since 4 years 10 months . was recorded as a recent event.
The activity Sudipta Chattopadhyay was appointed as a Director was appointed as a Director on 12 Mar 2020 & has been associated with this company since 5 years 9 months . was completed.
Shubhankar Karmakar was appointed as a Director was appointed as a Director on 01 Jan 2020 & has been associated with this company since 6 years 7 days . was recorded as a recent event.
Progress on Sohilkumar Dahyabhai Tandel was appointed as a Director was appointed as a Director on 16 Aug 2018 & has been associated with this company since 7 years 4 months . was documented.
The CIN of Esperer Bio-Research Private Limited is U24304MH2018PTC312841.
Esperer Bio-Research Private Limited is headquartered at Office No. 4Ba, 4Th Floor, Gundecha Onclave, Kherani Road, Sakinaka, Kurla W, Mumbai, Maharashtra, 400072.
Esperer Bio-Research Private Limited was incorporated on 16 August 2018.
The current directors of Esperer Bio-Research Private Limited are
The primary industry of Esperer Bio-Research Private Limited is Professional, Scientific And Technical.
Esperer Bio-Research Private Limited is unlisted.
The authorized capital of Esperer Bio-Research Private Limited is ₹6.50 Cr, and the paid-up capital is ₹4.40 Cr.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX